- Clinical Study
- Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study
-
Byung Sub Moon, Jongho Kim, Ji Hyun Kim, Young Youl Hyun, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Kyu-Beck Lee, Hyang Kim, Sung-Woo Park, Eun-Jung Rhee
-
Endocrinol Metab. 2016;31(3):402-409. Published online August 26, 2016
-
DOI: https://doi.org/10.3803/EnM.2016.31.3.402
-
-
4,555
View
-
33
Download
-
4
Web of Science
-
4
Crossref
-
Abstract
PDFPubReader
- Background
The purpose of this study was to investigate the relationship between statin eligibility and the degree of renal dysfunction using the Adult Treatment Panel (ATP) III and the American College of Cardiology (ACC)/American Heart Association (AHA) guidelines in Korean adults. MethodsRenal function was assessed in 18,746 participants of the Kangbuk Samsung Health Study from January 2011 to December 2012. Subjects were divided into three groups according to estimated glomerular filtration rate (eGFR): stage 1, eGFR ≥90 mL/min/1.73 m2; stage 2, eGFR 60 to 89 mL/min/1.73 m2; and stages 3 to 5, eGFR <60 mL/min/1.73 m2. Statin eligibility in these groups was determined using the ATP III and ACC/AHA guidelines, and the risk for 10-year atherosclerotic cardiovascular disease (ASCVD) was calculated using the Framingham Risk Score (FRS) and Pooled Cohort Equation (PCE). ResultsThere were 3,546 (18.9%) and 4,048 (21.5%) statin-eligible subjects according to ATP III and ACC/AHA guidelines, respectively. The proportion of statin-eligible subjects increased as renal function deteriorated. Statin eligibility by the ACC/AHA guidelines showed better agreement with the Kidney Disease Improving Global Outcomes (KDIGO) recommendations compared to the ATP III guidelines in subjects with stage 3 to 5 chronic kidney disease (CKD) (κ value, 0.689 vs. 0.531). When the 10-year ASCVD risk was assessed using the FRS and PCE, the mean risk calculated by both equations significantly increased as renal function declined. ConclusionsThe proportion of statin-eligible subjects significantly increased according to worsening renal function in this Korean cohort. ACC/AHA guideline showed better agreement for statin eligibility with that recommended by KDIGO guideline compared to ATP III in subjects with CKD.
-
Citations
Citations to this article as recorded by
- Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus
Honghong Ren, Lijun Zhao, Yutong Zou, Yiting Wang, Junlin Zhang, Yucheng Wu, Rui Zhang, Tingli Wang, Jiali Wang, Yitao Zhu, Ruikun Guo, Huan Xu, Lin Li, Mark E. Cooper, Fang Liu Renal Failure.2021; 43(1): 477. CrossRef - Long-term effects of various types of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on changes in glomerular filtration rate in Korea
Seo Yeon Baik, Hyunah Kim, So Jung Yang, Tong Min Kim, Seung-Hwan Lee, Jae Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, Kun-Ho Yoon, Hun-Sung Kim Frontiers of Medicine.2019; 13(6): 713. CrossRef - Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea
Y. J. Jeong, H. Kim, S. J. Baik, T. M. Kim, S. J. Yang, S.-H. Lee, J.-H. Cho, H. Lee, H. W. Yim, I. Y. Choi, K.-H. Yoon, H.-S. Kim Journal of Clinical Pharmacy and Therapeutics.2017; 42(3): 292. CrossRef - Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
Eugene Han, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Beom Seok Kim, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang Endocrinology and Metabolism.2017; 32(2): 274. CrossRef
- Adrenal gland
- Clinical Characteristics for 348 Patients with Adrenal Incidentaloma
-
Jongho Kim, Kwi Hyun Bae, Yeon Kyung Choi, Ji Yun Jeong, Keun Gyu Park, Jung Guk Kim, In Kyu Lee
-
Endocrinol Metab. 2013;28(1):20-25. Published online March 25, 2013
-
DOI: https://doi.org/10.3803/EnM.2013.28.1.20
-
-
4,473
View
-
43
Download
-
49
Crossref
-
Abstract
PDFPubReader
- Background
Adrenal incidentaloma is an adrenal neoplasm frequently encountered in clinical practice for which detection rates have recently increased. We describe here the clinical characteristics of adrenal incidentalomas. MethodsA retrospective study was performed examining the age, sex, location, size, function, and the histological findings for 348 patients with an adrenal mass discovered incidentally on computed tomography (CT) undertaken for health examination or nonadrenal disease from August 2005 to May 2012. ResultsPatients consisted of 156 males (44.8%) and 192 females (55.2%), aged between 20 and 86. Adrenal masses were most commonly found in patients in their sixth decade (32.5%). Regarding the location of the masses, 62.0% were found in the left adrenal gland, 30.2% were found in the right, and 7.8% were found bilaterally. Of all of the masses analyzed, 87.1% were 1 to 4 cm in size, and an adenoma-like appearance was the most common finding (75.3%) seen on CT scans. Hormonal analysis showed that 82.2% of the masses were nonfunctioning, 6.0% were diagnosed as subclinical Cushing's syndrome, 4.6% were aldosterone-producing adenomas, and 7.2% were pheochromocytomas. Adrenalectomy was performed in a total of 69 patients having adenoma (50.7%), pheochromocytoma (24.6%), and carcinoma (4.3%). ConclusionThe characteristics of benign, malignant, nonfunctional, and functional adrenal masses that were incidentally found at our hospital were similar to those presented in other studies.
-
Citations
Citations to this article as recorded by
- Impact of Size Thresholds on the Diagnosis of Incidental Adrenal Lesions: A Systematic Review and Meta-Analysis
Mitchell P. Wilson, Shubreet Randhawa, Bo Bao, Roger Croutze, Mohammad H. Murad, Matthew D.F. McInnes, Gavin Low Journal of the American College of Radiology.2024; 21(1): 107. CrossRef - Adrenal incidentalomas: A seven-year follow-up single-center experience
Danijela Radojković, Milica Pešić, Milan Radojković, Saša Radenković, Vojislav Ćirić, Ivan Ilić, Miloš Stević Acta Facultatis Medicae Naissensis.2024; 41(2): 252. CrossRef - Predictors of malignancy for treatment direction in patients with nonfunctioning adrenal incidentaloma
Jongwon Jung, Byung-Chang Kim, Douk Kwon, Won Woong Kim, Yu-mi Lee, Kye Jin Park, Seung Hun Lee, Ki-Wook Chung, Tae-Yon Sung Surgical Oncology.2024; 56: 102122. CrossRef - Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in South India: A Retrospective Study
Abhijeet B Jawanjal, Siddarth Sadananda, Nikitha Sriramaneni, Y. P. Ganavi, Pramila Kalra, Chitra Selvan, P. R. Manjunath, Praneethi K. Shetty Annals of African Medicine.2024; 23(4): 567. CrossRef - Quantitative analysis of catecholamines and their metabolites in 491 patients with adrenal tumors: a retrospective single-center cohort study
Hao-Long Zeng, Xu Wang, Hui-Jun Li, Qing Yang Journal of Cancer Research and Clinical Oncology.2023; 149(8): 4979. CrossRef - Biochemical Assessment of Pheochromocytoma and Paraganglioma
Graeme Eisenhofer, Christina Pamporaki, Jacques W M Lenders Endocrine Reviews.2023; 44(5): 862. CrossRef - Primary Aldosteronism Prevalence – An Unfolding
Story
Suranut Charoensri, Adina F. Turcu Experimental and Clinical Endocrinology & Diabetes.2023; 131(07/08): 394. CrossRef - Could the presence of adrenal incidentaloma negatively affect COVID 19 outcomes?
Metin Guclu, Bilal Burcak Aslan, Tirdad Setayeshi, Sinem Kiyici Endocrine.2023; 82(2): 406. CrossRef - Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
Mara Carsote, Ana-Maria Gheorghe, Claudiu Nistor, Alexandra-Ioana Trandafir, Oana-Claudia Sima, Anca-Pati Cucu, Adrian Ciuche, Eugenia Petrova, Adina Ghemigian Biomedicines.2023; 11(11): 3081. CrossRef - CT-based Abdominal Adipose Tissue Area Changes in Patients Undergoing Adrenalectomy Due to Cushing’s Syndrome and Non-functioning Adenomas
Elif Gündoğdu, Emre Emekli Experimental and Clinical Endocrinology & Diabetes.2022; 130(06): 368. CrossRef - The Etiological Profile of Adrenal Incidentalomas
Fatima-Zahra Lahmamssi, Loubna Saadaoui, Hayat Aynaou, Houda Salhi, Hanan El Ouahabi Cureus.2022;[Epub] CrossRef - A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
Yingshan Lee, Leon Yuan Rui Tan, Shaikh Abdul Kader Kamaldeen Abdul Shakoor Singapore Medical Journal.2022; 63(11): 649. CrossRef - Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma
Nusret Yilmaz, Esin Avsar, Gokhan Tazegul, Ramazan Sari, Hasan Altunbas, Mustafa Kemal Balci Experimental and Clinical Endocrinology & Diabetes.2021; 129(05): 349. CrossRef - A case of adrenocortical adenoma harboring venous thrombus mimicking adrenal malignancy
Agena Suzuki, Yuji Kamata, Tomomi Taguchi, Koji Takano, Yuto Yamazaki, Hironobu Sasano, Masayoshi Shichiri Endocrine Journal.2021; 68(7): 857. CrossRef - Adrenal adenomas: what to do with them? Review 2
S. Rybakov INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(3): 241. CrossRef - A Brief Overview of the Epidemiology of Pheochromocytoma and Paraganglioma in Korea
Yun Mi Choi Endocrinology and Metabolism.2020; 35(1): 95. CrossRef - Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study
Giuseppe Reimondo, Elena Castellano, Maurizio Grosso, Roberto Priotto, Soraya Puglisi, Anna Pia, Micaela Pellegrino, Giorgio Borretta, Massimo Terzolo The Journal of Clinical Endocrinology & Metabolism.2020; 105(4): e973. CrossRef - Adrenal İnsidentaloma ve Otonom Kortizol Sekresyonu Vakalarının İzlemi: 14 Yıllık Tek Merkez Çalışması- Retrospektif Kohort
Nazlı Gülsoy KIRNAP, Sanem ÖZTEKİN, Neslihan Başçıl TÜTÜNCÜ Dicle Tıp Dergisi.2020; 47(1): 154. CrossRef - Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan
Mari Aoe, Akira Okada, Tomoko Usui, Katsunori Manaka, Masaomi Nangaku, Noriko Makita Endocrine Journal.2020; 67(6): 645. CrossRef - Clinical outcomes of primary aldosteronism based on lateralization index and contralateral suppression index after adrenal venous sampling in real-world practice: a retrospective cohort study
Jeongmin Lee, Borami Kang, Jeonghoon Ha, Min-Hee Kim, Byungil Choi, Tae-Ho Hong, Moo IL Kang, Dong-Jun Lim BMC Endocrine Disorders.2020;[Epub] CrossRef - Adrenal Incidentaloma
Mark Sherlock, Andrew Scarsbrook, Afroze Abbas, Sheila Fraser, Padiporn Limumpornpetch, Rosemary Dineen, Paul M Stewart Endocrine Reviews.2020; 41(6): 775. CrossRef - Presentation and outcome of patients with an adrenal mass: A retrospective observational study
Nadeema Rafiq, Tauseef Nabi, SajadAhmad Dar, Shahnawaz Rasool Clinical Cancer Investigation Journal.2020; 9(5): 198. CrossRef - Enfoque diagnóstico de feocromocitomas y paragangliomas
R.M. Gómez, M. Hernaiz, V. de Miguel, L.S. Aparicio, M.J. Marín, S. Lupi, M. Barontini Hipertensión y Riesgo Vascular.2019; 36(1): 34. CrossRef - Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow‐up
Ana Ruiz, Theodora Michalopoulou, Ana Megia, Silvia Näf, Inmaculada Simón‐Muela, Esther Solano, Laia Martínez, Joan Vendrell European Journal of Clinical Investigation.2019;[Epub] CrossRef - Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism
Norio Wada, Yui Shibayama, Takashi Yoneda, Takuyuki Katabami, Isao Kurihara, Mika Tsuiki, Takamasa Ichijo, Yoshihiro Ogawa, Junji Kawashima, Masakatsu Sone, Takanobu Yoshimoto, Yuichi Matsuda, Megumi Fujita, Hiroki Kobayashi, Kouichi Tamura, Kohei Kamemur Journal of the Endocrine Society.2019; 3(7): 1393. CrossRef - Incidentally detected adrenal tumors – characteristics of patients and incidence of hormonal disorders
Iga Grochoła, Mateusz Winder, Krzysztof Kocot, Tomasz Menżyk, Jerzy Wojnar Annales Academiae Medicae Silesiensis.2019; 73: 74. CrossRef - Characteristics of Adrenal Incidentalomas in a Large, Prospective Computed Tomography-Based Multicenter Study: The COAR Study in Korea
Seong Hee Ahn, Jae Hyeon Kim, Seung Hee Baek, Hyeonmok Kim, Yoon Young Cho, Sunghwan Suh, Beom-Jun Kim, Seongbin Hong, Jung-Min Koh, Seung Hun Lee, Kee-Ho Song Yonsei Medical Journal.2018; 59(4): 501. CrossRef - Severe Cushing Syndrome Due to an ACTH-Producing Pheochromocytoma: A Case Presentation and Review of the Literature
Jenan N Gabi, Maali M Milhem, Yara E Tovar, Emhemmid S Karem, Alaa Y Gabi, Rodhan A Khthir Journal of the Endocrine Society.2018; 2(7): 621. CrossRef - Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome
Ichiro Abe, Kaoru Sugimoto, Tetsumasa Miyajima, Tomoko Ide, Midori Minezaki, Kaori Takeshita, Saori Takahara, Midori Nakagawa, Yuki Fujimura, Tadachika Kudo, Shigero Miyajima, Hiroshi Taira, Kenji Ohe, Tatsu Ishii, Toshihiko Yanase, Kunihisa Kobayashi Internal Medicine.2018; 57(17): 2467. CrossRef - Mortality in Patients with Endogenous Cushing’s Syndrome
Pedram Javanmard, Daisy Duan, Eliza B. Geer Endocrinology and Metabolism Clinics of North America.2018; 47(2): 313. CrossRef - The Lateralizing Asymmetry of Adrenal Adenomas
Meng Hao, Diana Lopez, Miguel Angel Luque-Fernandez, Kathryn Cote, Jessica Newfield, Molly Connors, Anand Vaidya Journal of the Endocrine Society.2018; 2(4): 374. CrossRef - Radiology of the adrenal incidentalomas. Review of the literature
F. A. Farrugia, G. Martikos, C. Surgeon, P. Tzanetis, E. Misiakos, N. Zavras, A. Charalampopoulos Endocrine Regulations.2017; 51(1): 35. CrossRef - Baseline Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in China: A Survey
Lele Li, Guoqing Yang, Ling Zhao, Jingtao Dou, Weijun Gu, Zhaohui Lv, Juming Lu, Yiming Mu International Journal of Endocrinology.2017; 2017: 1. CrossRef - Guidelines for the Management of Adrenal Incidentaloma: the Korean Endocrine Society, Committee of Clinical Practice Guidelines
Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang-Wan Kim, Soo-Kyung Kim, Hae-Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung-Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo The Korean Journal of Medicine.2017; 92(1): 4. CrossRef - Case Report: An incidentaloma that catches your eye - adrenal myelolipoma
Rosanna D'Addosio, Joselyn Rojas, Valmore Bermúdez, Flor Ledesma, Kyle Hoedebecke F1000Research.2017; 6: 1140. CrossRef - Clinical Guidelines for the Management of Adrenal Incidentaloma
Jung-Min Lee, Mee Kyoung Kim, Seung-Hyun Ko, Jung-Min Koh, Bo-Yeon Kim, Sang Wan Kim, Soo-Kyung Kim, Hae Jin Kim, Ohk-Hyun Ryu, Juri Park, Jung Soo Lim, Seong Yeon Kim, Young Kee Shong, Soon Jib Yoo Endocrinology and Metabolism.2017; 32(2): 200. CrossRef - PIRMĄ KARTĄ NUSTATYTI ANTINKSČIŲ DARINIAI:
2010 IR 2014 METŲ IŠTYRIMO TAKTIKOS PALYGINIMAS
Lina Ščerbinskaitė, Aušra Bradulskytė, Milda Girdžiūtė, Vilija Guntaitė, Žydrūnė Visockienė Sveikatos mokslai.2017; 27(2): 60. CrossRef - Clinical significance of screening for subclinical Cushing’s disease in patients with pituitary tumors
Daisuke Tamada, Tetsuhiro Kitamura, Michio Otsuki, Satoru Oshino, Youichi Saitoh, Iichiro Shimomura Endocrine Journal.2016; 63(1): 47. CrossRef - Evaluación diagnóstica y terapéutica del incidentaloma suprarrenal
Reynaldo M. Gómez, Raul Chervín, Ester M. Pardes, Susana Lupi, María Elena Surraco, Jorge Herrera, León Schurman, Claudio Gonzáles Revista Argentina de Endocrinología y Metabolismo.2016; 53(2): 51. CrossRef - Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan
Yukiko Tabuchi, Michio Otsuki, Soji Kasayama, Keisuke Kosugi, Kunihiko Hashimoto, Tsunehiko Yamamoto, Mamiko Tsugawa, Ikuo Mineo, Yuya Yamada, Shogo Kurebayashi, Makoto Ohashi, Yutaka Umayahara, Haruhiko Kouhara, Tadashi Nakamura, Hideki Taki, Taka-aki Ma Endocrine Journal.2016; 63(1): 29. CrossRef - Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma
Yun Mi Choi, Hyemi Kwon, Min Ji Jeon, Tae-Yon Sung, Suck Joon Hong, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Jae Lyun Lee, Dong Eun Song, Won Gu Kim Medicine.2016; 95(21): e3736. CrossRef - Screening for Cushing’s syndrome: Is it worthwhile?
Ilan Shimon Pituitary.2015; 18(2): 201. CrossRef - Subclinical hypercortisolism in adrenal incidentaloma
Miguel Debono, John Newell-Price Current Opinion in Endocrinology, Diabetes & Obesity.2015; 22(3): 185. CrossRef - Incidental Adrenal Nodules and Masses: The Imaging Approach
J. Willatt, S. Chong, J. A. Ruma, J. Kuriakose International Journal of Endocrinology.2015; 2015: 1. CrossRef - Adrenal Incidentalomas
Adriana G. Ioachimescu, Erick M. Remer, Amir H. Hamrahian Endocrinology and Metabolism Clinics of North America.2015; 44(2): 335. CrossRef - Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
Won-Young Lee Endocrinology and Metabolism.2014; 29(3): 251. CrossRef - Clinical Characteristics and Metabolic Features of Patients with Adrenal Incidentalomas with or without Subclinical Cushing's Syndrome
Bo-Yeon Kim, A-Reum Chun, Kyu-Jin Kim, Chan-Hee Jung, Sung Koo Kang, Ji-Oh Mok, Chul-Hee Kim Endocrinology and Metabolism.2014; 29(4): 457. CrossRef - A rare cause of Cushing's syndrome: an ACTH-secreting phaeochromocytoma
Lars Folkestad, Marianne Skovsager Andersen, Anne Lerberg Nielsen, Dorte Glintborg BMJ Case Reports.2014; : bcr2014205487. CrossRef - ADRENAL INCIDENTALOMAS: DIAGNOSIS AND MANAGEMENT
E. N. Grineva, L. V. Belousova, I. V. Basek "Arterial’naya Gipertenziya" ("Arterial Hypertension").2013; 19(6): 532. CrossRef
|